Jupiter Neurosciences, Inc. (JUNS)

Jupiter Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.77	0.03	0.06	0.33	0.21
Cash & Short-Term Investments	3.77	0.03	0.06	0.33	0.21
Cash Growth	13136.57%	-55.80%	-80.51%	58.95%	16200.78%
Other Receivables	-	-	-	-	0.13
Receivables	-	-	-	-	0.13
Prepaid Expenses	0.88	0	-	-	-
Other Current Assets	-	-	0.01	0.12	0.22
Total Current Assets	4.65	0.03	0.07	0.45	0.55
Property, Plant & Equipment	0.07	0.12	0.16	0.21	-
Other Long-Term Assets	1.48	0	0	0	-
Total Assets	6.2	0.15	0.24	0.67	0.55
Accounts Payable	0.28	0.19	0.19	0.26	0.25
Accrued Expenses	1.53	1.97	4.58	4.59	3.9
Short-Term Debt	0.15	2.02	1.73	0.44	0.11
Current Portion of Leases	0.05	0.05	0.05	0.05	-
Other Current Liabilities	0	1.54	0.71	0.35	-
Total Current Liabilities	2.01	5.77	7.26	5.68	4.26
Long-Term Debt	-	0.11	-	-	-
Long-Term Leases	0.02	0.07	0.12	0.16	-
Total Liabilities	2.03	5.95	7.38	5.85	4.26
Common Stock	0	0	0	0	0
Additional Paid-In Capital	30.19	17.78	11.65	8.66	6.43
Retained Earnings	-26.02	-23.58	-18.8	-13.84	-9.64
Comprehensive Income & Other	-	-	-	-	-0.5
Shareholders' Equity	4.17	-5.8	-7.14	-5.18	-3.71
Total Liabilities & Equity	6.2	0.15	0.24	0.67	0.55
Total Debt	0.22	2.25	1.9	0.65	0.11
Net Cash (Debt)	3.55	-2.22	-1.83	-0.32	0.1
Net Cash Per Share	0.12	-0.08	-0.07	-0.01	0.00
Filing Date Shares Outstanding	33.1	26.53	25.45	24.52	23.52
Total Common Shares Outstanding	33.1	26.53	25.45	24.52	23.52
Working Capital	2.64	-5.74	-7.19	-5.23	-3.71
Book Value Per Share	0.13	-0.22	-0.28	-0.21	-0.16
Tangible Book Value	4.17	-5.8	-7.14	-5.18	-3.71
Tangible Book Value Per Share	0.13	-0.22	-0.28	-0.21	-0.16

Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q